Kumbhari A, Cheng TNH, Ananthakrishnan AN, et al. Discovery of disease-adapted bacterial lineages in inflammatory bowel diseases. Cell host & microbe. 2024. doi:10.1016/j.chom.2024.05.022.
Takashima Y, Kawamura H, Okadome K, et al. Enrichment of Bacteroides fragilis and enterotoxigenic Bacteroides fragilis in CpG island methylator phenotype (CIMP)-high colorectal carcinoma. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases. 2024. doi:10.1016/j.cmi.2024.01.013.
Bai G-H, Tsai M-C, Lin S-C, Hsu Y-H, Chen S-Y. Corrigendum: Unraveling the interplay between norovirus infection, gut microbiota, and novel antiviral approaches: a comprehensive review. Frontiers in microbiology. 2023;14:1324539. doi:10.3389/fmicb.2023.1324539.
Bai G-H, Tsai M-C, Lin S-C, Hsu Y-H, Chen S-Y. Unraveling the interplay between norovirus infection, gut microbiota, and novel antiviral approaches: a comprehensive review. Frontiers in microbiology. 2023;14:1212582. doi:10.3389/fmicb.2023.1212582.
Sinha R, Ahsan H, Blaser M, et al. Next steps in studying the human microbiome and health in prospective studies, Bethesda, MD, May 16-17, 2017. Microbiome. 2018;6(1):210. doi:10.1186/s40168-018-0596-z.
Lloyd-Price J, Mahurkar A, Rahnavard G, et al. Strains, functions and dynamics in the expanded Human Microbiome Project. Nature. 2017;550(7674):61-66. doi:10.1038/nature23889.
Mehta RS, Abu-Ali GS, Drew DA, et al. Stability of the human faecal microbiome in a cohort of adult men. Nat Microbiol. 2018;3(3):347-355. doi:10.1038/s41564-017-0096-0.
Bullman S, Pedamallu CS, Sicinska E, et al. Analysis of persistence and antibiotic response in colorectal cancer. Science. 2017;358(6369):1443-1448. doi:10.1126/science.aal5240.